SCHEMBL30879199

SCHEMBL30879199

Nc1ccc(N2CCC(N3CC(CO)C3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 11/20 0.49
▸ L3MBTL3 Q96JM7 11/20 0.49
▸ MAPT P10636 4/20 0.45
▸ GFER P55789 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ GAA P10253 3/20 0.45
▸ RAD52 P43351 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDM1A O60341 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ HTT P42858 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL520612 0.84 MAPT (0.50) L3MBTL1L3MBTL3MAPTGFERKDM4E
SCHEMBL16445747 0.83 L3MBTL1 (0.53) L3MBTL1L3MBTL3MAPTGFERKDM4E
Hydrochloric Acid SCHEMBL3566395 0.82 MAPT (0.53) L3MBTL1L3MBTL3MAPTGFERKDM4E
SCHEMBL30879285 0.81 MAPT (0.45) L3MBTL1L3MBTL3MAPTGFERKDM4E
SCHEMBL15651591 0.81 MAPT (0.43) L3MBTL1MAPTGFERKDM4EGAA
SCHEMBL13735219 0.81 MAPT (0.43) L3MBTL1MAPTGFERKDM4EGAA
SCHEMBL15652597 0.81 MAPT (0.43) L3MBTL1MAPTGFERKDM4EGAA
SCHEMBL23983401 0.80 MAPT (0.44) L3MBTL1MAPTGFERKDM4EGAA
SCHEMBL2236451 0.77 L3MBTL3 (0.81) L3MBTL1L3MBTL3MAPTGFERKDM4E
SCHEMBL16446432 0.77 L3MBTL1 (0.50) L3MBTL1L3MBTL3MAPTGFERKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 — — WO disclosed
Send feedback